14th Jan 2014 11:40
LONDON (Alliance News) - TyraTech Inc Tuesday said its Vamousse head-lice treatment will be sold in Walmart stores across the US from the end of March.
The life sciences firm said the head-lice control market in the US is worth around USD150 million and hopes its Vamousse product will make an impact.
"This is our most important milestone to date, as it will significantly raise the profile of TyraTech's brands in the US, helping us further expand our market penetration and market share," Chief Executive Bruno Jactel said in a statement.
"In addition, the fact that Vamousse will come to Walmart stores reinforces our strategy of establishing our own brands within the market place," he added.
The stock was trading at 5.00 pence Tuesday morning, up 0.38 pence or 8.1%.
By Anthony Tshibangu; [email protected]; @AnthonyAllNews
Copyright © 2014 Alliance News Limited. All Rights Reserved.